FocusPolicy

Medication development in opioid addiction: Meaningful clinical end points

See allHide authors and affiliations

Science Translational Medicine  28 Mar 2018:
Vol. 10, Issue 434, eaan2595
DOI: 10.1126/scitranslmed.aan2595

Article Information

vol. 10 no. 434

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication March 18, 2017
  • Accepted for publication December 15, 2017
  • .

Author Information

  1. Nora D. Volkow1,*,
  2. Janet Woodcock2,
  3. Wilson M. Compton1,
  4. Douglas C. Throckmorton2,
  5. Phil Skolnick1,
  6. Sharon Hertz2 and
  7. Eric M. Wargo1
  1. 1National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, USA.
  2. 2Food and Drug Administration, Silver Spring, MD 20892, USA.
  1. *Corresponding author. Email: nvolkow{at}nida.nih.gov

Altmetric

Article usage

Article usage: March 2018 to December 2019

AbstractFullPdf
Mar 20182392173131
Apr 20181630167162
May 20183724533
Jun 20183554127
Jul 20184024126
Aug 20182189772
Sep 20181673225
Oct 20182014226
Nov 20181673928
Dec 2018952814
Jan 20191382816
Feb 20191381018
Mar 20191011518
Apr 20191263413
May 20191032011
Jun 2019681313
Jul 2019571411
Aug 201950117
Sep 2019693318
Oct 20191042114
Nov 2019841110
Dec 20193373

Stay Connected to
   Science Translational Medicine